clinical trial · NCT04052698
Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD
Octapharma·phase3·completed·n = 43
Von Willebrand DiseasesWilate
brief summary
This is a prospective, non-controlled, international, multi-center phase 3 study investigating the efficacy and safety of Wilate in previously treated adult patients with VWD, to obtain additional data on the safety and efficacy of Wilate in previously treated patients with VWD undergoing regular prophylaxis.
started
Jun 18, 2020
primary completion
Apr 23, 2022
completion
Apr 23, 2022
last updated
Oct 25, 2023
official title
Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With Von Willebrand Disease (VWD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol